Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
720.28
644.86
620.38
507.44
427.30
401.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
720.28
644.86
620.38
507.44
427.30
401.15
Raw Material Cost
455.12
405.92
414.03
313.71
241.57
245.98
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
79.36
73.32
61.28
49.07
37.49
33.15
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.35
0.17
6.96
6.78
3.86
4.56
Selling and Distribution Expenses
33.76
31.78
33.44
38.92
23.85
18.01
Other Expenses
-3.13
-2.63
-4.06
-3.74
-2.23
-2.18
Total Expenditure (Excl Depreciation)
537.24
484.85
475.07
371.10
284.44
279.87
Operating Profit (PBDIT) excl Other Income
183
160
145.29999999999998
136.3
142.89999999999998
121.30000000000001
Other Income
18.52
20.99
3.50
2.32
1.43
9.43
Operating Profit (PBDIT)
239.49
215.37
173.21
159.53
162.24
147.12
Interest
0.35
0.17
6.96
6.78
3.86
4.56
Exceptional Items
-1.72
-1.42
1.04
0.06
-3.00
0.00
Gross Profit (PBDT)
265.16
238.94
206.35
193.73
185.72
155.17
Depreciation
40.07
32.62
24.40
20.86
17.95
16.42
Profit Before Tax
197.35
181.16
142.88
131.94
137.43
126.14
Tax
24.34
23.96
11.17
17.11
18.97
16.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
173.63
158.98
132.30
114.98
118.46
109.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
173.63
158.98
132.30
114.98
118.46
109.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.62
-1.78
-0.60
-0.15
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
173.01
157.20
131.71
114.82
118.46
109.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,542.19
1,448.02
1,355.94
402.53
313.39
191.38
Earnings per share (EPS)
0.44
0.41
0.34
0.29
0.3
0.28
Diluted Earnings per share
0.44
0.41
0.34
0.29
0.3
0.28
Operating Profit Margin (Excl OI)
25.12%
25.09%
23.42%
26.87%
33.43%
30.23%
Gross Profit Margin
32.96%
33.15%
26.97%
30.11%
36.36%
35.54%
PAT Margin
24.11%
24.65%
21.33%
22.66%
27.72%
27.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 11.69% vs 3.95% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 10.05% vs 19.36% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 13.68% vs 14.56% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is 100.00% vs -97.14% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Newland Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
720.28
0
720.28
Other Operating Income
0.00
0.00
0.00
Total Operating income
720.28
0
720.28
Raw Material Cost
455.12
0
455.12
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
79.36
0
79.36
Power Cost
0
0
0.00
Manufacturing Expenses
0.35
0
0.35
Selling and Distribution Expenses
33.76
0
33.76
Other Expenses
-3.13
0.00
-3.13
Total Expenditure (Excl Depreciation)
537.24
0
537.24
Operating Profit (PBDIT) excl Other Income
183.03
0.00
183.03
Other Income
18.52
0
18.52
Operating Profit (PBDIT)
239.49
0
239.49
Interest
0.35
0
0.35
Exceptional Items
-1.72
0
-1.72
Gross Profit (PBDT)
265.16
0
265.16
Depreciation
40.07
0
40.07
Profit Before Tax
197.35
0
197.35
Tax
24.34
0
24.34
Provisions and contingencies
0
0
0.00
Profit After Tax
173.63
0
173.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
173.63
0
173.63
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.62
0
-0.62
Other related items
0.00
0.00
0.00
Consolidated Net Profit
173.01
0
173.01
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,542.19
0
1,542.19
Earnings per share (EPS)
0.44
0
0.44
Diluted Earnings per share
0.44
0
0.44
Operating Profit Margin (Excl OI)
25.12%
0%
0.00
25.12%
Gross Profit Margin
32.96%
0%
0.00
32.96%
PAT Margin
24.11%
0%
0.00
24.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 72.03 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 11.69% vs 3.95% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 17.30 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 10.05% vs 19.36% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 22.10 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 13.68% vs 14.56% in Dec 2023
Annual - Interest
Interest 0.04 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 100.00% vs -97.14% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.12%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
